Cytomegalovirus esophagitis with symptoms of gastroesophageal reflux disease in a kidney transplant recipient

Kaohsiung J Med Sci. 2020 Oct;36(10):859-860. doi: 10.1002/kjm2.12264. Epub 2020 Jul 15.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use
  • Convalescence
  • Cytomegalovirus / drug effects
  • Cytomegalovirus / growth & development
  • Cytomegalovirus / immunology
  • Cytomegalovirus / pathogenicity*
  • Cytomegalovirus Infections / drug therapy
  • Cytomegalovirus Infections / immunology
  • Cytomegalovirus Infections / physiopathology*
  • Cytomegalovirus Infections / virology
  • Endoscopy, Digestive System
  • Esophagitis / drug therapy
  • Esophagitis / immunology
  • Esophagitis / physiopathology*
  • Esophagitis / virology
  • Female
  • Gastroesophageal Reflux / drug therapy
  • Gastroesophageal Reflux / immunology
  • Gastroesophageal Reflux / physiopathology*
  • Gastroesophageal Reflux / virology
  • Humans
  • Immunocompromised Host*
  • Kidney / immunology
  • Kidney / physiopathology
  • Kidney / surgery
  • Kidney / virology
  • Kidney Transplantation*
  • Middle Aged
  • Renal Insufficiency, Chronic / immunology
  • Renal Insufficiency, Chronic / physiopathology
  • Renal Insufficiency, Chronic / surgery
  • Renal Insufficiency, Chronic / virology
  • Valganciclovir / therapeutic use

Substances

  • Antiviral Agents
  • Valganciclovir